Contraceptive and hormonal treatment options for women with history of venous thromboembolism
Stam-Slob, M.C.; Lambalk, C.B.; van de Ree, M.A.
Bmj 351: H4847
2015
ISSN/ISBN: 1756-1833 PMID: 26450167 DOI: 10.1136/bmj.h4847Document Number: 640237
Document emailed within 0-6 h
Related Documents
Sarig, G.; Aberbach, I.; Schliamser, L.; Blumenfeld, Z.; Brenner, B. 2006: Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy Thrombosis and Haemostasis 96(5): 578-583Hugon-Rodin, J.; Horellou, M.-H.él.èn.; Conard, J.; Flaujac, C.; Gompel, A.; Plu-Bureau, G.èv. 2017: First venous thromboembolism and hormonal contraceptives in young French women Medicine 96(34): E7734
Gensini, G.F.; Rostagno, C.; Caciolli, S. 1998: Treatment options for acute venous thromboembolism in the older patient Geriatrics 53(1): 34-36; 39-40; 46-47
Margarido, P.F.R.; Bagnoli, V.R.; Maggio da Fonseca, A.; Maciel, G.A.R.; Soares, J.M.; D'Amico, E.A.; Baracat, E.C. 2011: Transdermal estrogen therapy effects on fibrinogen levels in women with a past history of venous thromboembolism: a pilot study Clinical and Experimental Obstetrics and Gynecology 38(3): 232-235
Hugon-Rodin, J.; Gompel, A.; Plu-Bureau, G.èv. 2014: Epidemiology of hormonal contraceptives-related venous thromboembolism European Journal of Endocrinology 171(6): R221-R230
Plu-Bureau, G.; Maitrot-Mantelet, L.; Hugon-Rodin, J.; Canonico, M. 2013: Hormonal contraceptives and venous thromboembolism: an epidemiological update Best Practice and Research. Clinical Endocrinology and Metabolism 27(1): 25-34
Bergendal, A.; Persson, I.; Odeberg, J.; Sundström, A.; Holmström, M.; Schulman, S.; Björgell, O.; Kieler, H. 2014: Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes Obstetrics and Gynecology 124(3): 600-609
Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
Crespi, S.; Kerrigan, M.; Sood, V. 2013: Budget impact analysis of 8 hormonal contraceptive options American Journal of Managed Care 19(7): E249-E255
Helmrich, S.P.; Rosenberg, L.; Kaufman, D.W.; Strom, B.; Shapiro, S. 1987: Venous thromboembolism in relation to oral contraceptive use Obstetrics and Gynecology 69(1): 91-95
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967
Spencer, F.A.; Gore, J.M.; Reed, G.; Lessard, D.; Pacifico, L.; Emery, C.; Crowther, M.A.; Goldberg, R.J. 2009: Venous thromboembolism and bleeding in a community setting. the Worcester Venous Thromboembolism Study Thrombosis and Haemostasis 101(5): 878-885
Betancourt, M.T.; Rodger, M.A. 2007: Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients Acta Chirurgica Belgica 107(6): 636-640
Vasilakis, C.; Jick, S.S.; Jick, H. 1999: The risk of venous thromboembolism in users of postcoital contraceptive pills Contraception 59(2): 79-83
Shapiro, S. 2013: Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases Journal of Family Planning and Reproductive Health Care 39(2): 89-96
Burnayeva, S.V.; Vasilyeva, I.I.; Gavrisyuk, V.K.; Gerasimenko, S.I.; Gudz, I.M.; Dzyublik, A.Ya.; Dzyak, G.V.; Zharinov, O.I.; Kobza, I.I.; Kovalev, A.A.; Kolesnik, E.A.; Kostylev, M.V.; Kulik, I.V.; Lutay, Y.M.; Mishalov, V.G.; Mishchenko, T.S.; Nikonenko, A.S.; Nikonenko, A.A.; Nikulnikov, P.I.; Parkhomenko, A.N.; Polulyakh, M.V.; Rudenko, K.V.; Skupoy, O.M.; Tatarchuk, T.F.; Todurov, B.M.; Usenko, A.Yu.; Feshchenko, Y.I.; Chernukha, I.M.; Yachnik, A.I. 2017: The Experts Consensus for Anticoagulant Therapy of Venous Thromboembolism in 2016 Yr. Significance of the Rivaroxaban Investigations Program for Changes of Approaches, Concerning Treatment of the Deep Veins Thrombosis and Pulmonary Thromboembolism Klinichna Khirurhiia 2017(3): 65-80
Braithwaite, I.; Shirtcliffe, P.; Weatherall, M.; Beasley, R. 2016: Anti-androgen contraceptive pills and higher risk of venous thromboembolism New Zealand Medical Journal 129(1430): 102-104
Mokosáková, M.; Krsková, L.; Hlavacka, F.; Zeman, M. 2014: Diurnal changes of the postural control in young women without and with hormonal contraceptive treatment Neuro Endocrinology Letters 35(3): 230-235
Mokosáková, M.; Krsková, L.; Hlavacka, F.; Zeman, M. 2014: Diurnal changes of the postural control in young women without and with hormonal contraceptive treatment Neuro Endocrinology Letters 35(3): 230-235
Gerstman, B.B.; Piper, J.M.; Freiman, J.P.; Tomita, D.K.; Kennedy, D.L.; Ferguson, W.J.; Bennett, R.C. 1990: Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolism International Journal of Epidemiology 19(4): 931-936